Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by PD-L1 immunohistochemistry (IHC) assays and blood tumour mutational burden (bTMB): IMpower110

---

Copy For Citation

Herbst R. S., De Marinis F., Giaccone G., Stahel R., Reinmuth N., Vergnenegre A., ...More

SWISS MEDICAL WEEKLY, 2020 (SCI-Expanded)

• Publication Type: Article / Abstract
• Volume:
• Publication Date: 2020
• Journal Name: SWISS MEDICAL WEEKLY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Istanbul University Affiliated: No